Over 10 years experience of Traceability Solutions
By pharmatrax
Category: News
No Comments
Valisure warns FDA officials that the pharmacy found high levels of dimethylformamide in valsartan, a heart pill manufactured by Novartis. Valisure is an online pharmacy…
By pharmatrax
Category: News
No Comments
Medtronic is recalling older, discontinued versions of its MiniMed insulin pump over potential cybersecurity risks, saying they may be vulnerable to unwanted, remote settings changes.…
By pharmatrax
Category: News
No Comments
Google is being sued in a potential class-action lawsuit which accuses the tech giant of inappropriately accessing sensitive medical records belonging to hundreds of thousands…
By pharmatrax
Category: News
No Comments
From automated eye scans to analysing the cries of new-born babies, faster drug development to personalised medicine, artificial intelligence (AI) promises huge advances in the…
By pharmatrax
Category: Technoloy
No Comments
Sanofi will apply Google’s artificial intelligence (AI) and cloud computing capabilities toward developing new drugs, through a collaboration whose value was not disclosed. The companies…
By pharmatrax
Category: Technoloy
No Comments
Politicians and even knowledgeable industry observers have called for price controls to deal with what many see as a crisis in drug pricing. Can pricing boards do…
By pharmatrax
Category: News
No Comments
Pharmacy finds DMF in valsartan, adding to anxiety on recalls Results raise questions on safety, oversight of supply chain An online pharmacy told U.S. regulators…
By pharmatrax
Category: News
No Comments
The Bureau of Pharma PSUs of India (BPPI), which implements the Centre’s flagship affordable medicine scheme PMBJP, has found 25 batches of drugs of 18…
By pharmatrax
Category: Technoloy
No Comments
Telling the fake from the true is often a challenge, particularly in this era of ‘fake news’. But, for medicines at least, that’s just become…
By pharmatrax
Category: Technoloy
No Comments
Technology companies like Amazon, Google, Apple and Microsoft keep making moves in the health sector, which isn’t surprising given that it represents a $3.5 trillion opportunity. But these companies keep hitting…